Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Attracting NEW Investors - BOD NEEDS TO TAKE ACTION!

Opty,

I agree that the MMP value has tremendous value and the "street" or new investors will see that in the near future. The question still remains though: What will the PTSC BOD do with all the future revenues? As LL has pointed out in many posts, the MMP has already produced a good amount of revenues. I think many of us here believe we would be in much better shape if those revenues were used more wisely (i.e. result would be higher than $0.12 a share). I believe in the patents and I believe the patents will generate revenues. I just hope whoever is in charge uses those revenues to produce a much higher share price. Past history doesn't necessarily determine future events, however, something has to change otherwise the past may repeat itself, IMO.

Share
New Message
Please login to post a reply